Best-worst scaling to assess the most important barriers and facilitators for the use of health technology assessment in Austria.
Chiara FeigKei-Long CheungMickaël J C HiligsmannSilvia M A A EversJudit SimonSusanne MayerPublished in: Expert review of pharmacoeconomics & outcomes research (2017)
This study suggests that HTA barriers and facilitators related to the context of decision makers, especially 'policy characteristics' and 'organization and resources' are the most important in Austria. A transparent and participatory decision-making process could improve the adoption of HTA evidence.